support this view. Furthermore, several open questions still hamper the quantitative estimation of the role that family history plays in CHD. Among these, the most relevant include the definition of exposure (in terms of number and age of relatives affected) and the potential modifying effect of serum cholesterol and other covariates (which are possibly subject to random error and bias). Moreover, the interaction between family history and major recognized risk factors for ischemic heart disease has not been adequately investigated.
To obtain further information on this topic, we collected data on the family history of patients with acute myocardial infarction (MI) in a large case-control study conducted in Italy within the framework of the GISSI-2 (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico) Trial.18 Methods The present case-control study was conducted in 90 of the 223 hospitals involved in the GISSI-2 Trial, which was spread over the whole territory. These hospitals Odds ratios as estimators of relative risks (RR) of acute MI, together with their 95% approximate confidence intervals (CI), were computed using the MantelHaenszel procedure.'9 The significance of the linear trends in risk was assessed by using the x2 test as described by Mantel.20 In addition, the potential reciprocal confounding effects of several factors (sex, age, cigarette smoking, cholesterol levels, diabetes, body mass index, hypertension, hyperlipidemia, and total number of relatives) were simultaneously controlled using unconditional multiple logistic regression. 2' Results Table 1 gives the distribution of case and control patients according to sex and the selected variables. The case and control groups were comparable in relation to sex and age. As expected, most of the variables considered appeared more frequently in case patients than in control patients. This applies particularly to hypercholesterolemia, hypertension, and hyperlipemia, whose frequency in cases of both sexes is almost twofold as high as that in control groups. It also applies to smoking in men, and is even more apparent in smoking and diabetes in women: the frequency of heavy smokers and diabetes among women is 16.5% and 23.5% in case groups compared with 2.3% and 8.5% in control groups.
Family history of MI in first-degree relatives of case and control patients and their subgroups by sex is described in Table 2 . A family history concerning at least one relative was present in 34.8% of case patients compared with 19 .5% of control patients; 8 .6% of case patients had a family history of MI involving at least two relatives, compared with only 3.5% of control patients. Moreover, male but not female case patients had a higher percentage of fathers with MI (16.4%) than corresponding control patients (9.9%). In contrast, the percentage of mothers with MI was higher in female (10.4%) than in male case patients compared with control patients (4.6%).
The RR of MI among case patients of either sex with a positive family history compared with subjects with a negative family history is reported in Table 3 . The risk increased twofold to fourfold in subjects with a family history compared with those without. Such an increase was not substantially affected by allowance for a number of identified potentially distorting factors (including recognized major risk factors for MI) by means of multiple logistic regression. Indeed, the RR estimated by the Mantel-Haenszel test is 2.0 (95% CI, 1.6-2.5) when at least one relative is affected, 3 .0 (95% CI, 2.0-4.4) when at least two relatives are affected (test for trend, X2=544.l;p<00Ol), 3 .4 (95% CI, 2.4-4.7) when one sibling is affected, and 4.6 (95% CI, 2.2-9.5) when two siblings are affected (test for trend, X 2l =56.5; p<O.OOl). According to multiple logistic regression analysis, the corresponding RRs are 2.1 (95% CI, 1.6-2.6), 3.0 (95% CI, 1.9-4.5), 3 .4 (95% CI, 2.4-4.9), and 4.7 (95% CI, 2.1-10.6).
In both sexes, the risk apparently increased according to the number of relatives affected. Although the RRs themselves seem to support a relation between men and women and their fathers' and mothers' histories of MI, respectively, the wide CIs do not allow any definitive conclusion on this issue.
The RR for MI in relation to the number of relatives affected in selected covariates is presented in Table 4 . In most of the subgroups, the trend toward a higher risk for patients with one, two, or more relatives with MI compared with those without a family history was statistically significant. The few exceptions (mild smokers, diabetics) might well be due to the relatively small sample size of those subgroup categories and the role of chance.
To investigate the possible interaction between family history and known risk factors, the RR for each of these was evaluated, both alone and in combination with the presence of a family history of MI. The effect on RR was approximately multiplicative for several variables, including smoking, serum cholesterol, hypertension, and hyperlipidemia, but not for diabetes and body mass index. In formal statistical terms, however, the deviation from the multiplicative model was not significant (Table  5 ). This effect was particularly evident in current smokers, in whom the RR increased from 6.2 (95% CI, 2.9-13.2) in those with a negative family history to 14.0 Barrett-Connor and Khaw9 found that, during 9 years of follow-up, men with MI occurring under the age of 60 years had a risk of mortality from CHD fivefold higher than those without a family history; the risk was independent from the major recognized risk factors, and no excess risk was found in men older than 60 years or in women. The independent predictive value of family history was confirmed by Myers et al'2 in the Framingham study as well as by Hopkins et al'0 in a study including the analysis of high density lipoprotein cholesterol among other risk factors and more recently by Colditz et al, 14 who also took diet into consideration.
Our study shows that the risk of MI associated with family history is elevated in subjects of either sex, in various strata of age, smoking habits, and other major covariates investigated. Although it was missing in most of previous studies concerning only men, this finding is in agreement with the results of other studies of either both sexes' 11'2 or women only23 as well as with those of the only prospective study conducted exclusively on women.'3 The degree of risk may vary markedly according to the number of relatives affected, which relative is affected, and the age at which they are affected.'7,24 
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For some variables, the sum of the strata does not add to the total because of missing values. Estimates are from multiple logistic regression equations including terms for age, sex, smoking, cholesterol levels, diabetes, body mass index, hypertension, hyperlipidemia, and total number of relatives. *p<O.001; tp<O.05.
Our study shows that the risk was significantly related to the number of relatives affected. Although the wide CI does not allow any definitive conclusion, there is a suggestion that women have a higher risk when their mother or siblings have had an MI. The same trend is true for men in respect to their fathers, and the risk is greatest if their siblings have a history of MI. A stronger relation between paternal rather than maternal history of MI and risk of CHD has been reported,1.3 but this is not apparent in more recent work." 113"14
Regarding age, RR apparently increases (particularly if two or more relatives are affected) if the MI in relatives occurs early (<55 years) rather than late (c65 years), and this increased risk has long been accepted.14,59,114 These data support the hypothesis of a genetic component of the family history possibly conditioning the development of CHD. Indeed, genetic influence is more likely in younger than in older people, in whom other environmental factors may have exerted their effect, possibly diluting a genetic predisposition. Estimates are from multiple logistic regression equations including terms for age, sex, smoking, cholesterol levels, diabetes, body mass index, hypertension, hyperlipidemia, and total number of relatives.
*Reference category.
In our study, body mass index and diabetes appeared to have an additive interaction with family history on the risk of acute MI. However, when smoking, serum cholesterol level, hypertension, or hyperlipidemia were considered in relation to the interaction they had with family history, the effect on RR appeared to be multiplicative. This could explain why a single risk factor, though sufficient itself in the long term (the RR increases), may be necessary but not sufficient for a fast development of a multifactorial process like atherogenesis unless other concomitant factors contribute to the development of MI. This again supports a genetic rather than a familial environment-related risk. In this case, the dominant effect of familiality is probably due to the fact that genetic influence may involve more than one mechanism leading to atherosclerotic lesions. The effect of smoking in the presence of family history reported in this study was observed by others1525,26 as well; however, our data are in contrast with the lack of a significant interaction between major recognized risk factor and parental coronary artery disease, as reported by Myers et al.12 Different definitions of family history (parental death for CAD instead of MI occurrence in firstdegree relatives) and differences in study population and methodology could explain these inconsistencies.
The methodology adopted in this study has several strengths as well as limitations. Using a case-control design, we were able to collect information on risk factors for MI from a large sample size in a short period of time, allowing reliable estimates of the variable considered.
Although collected by ad hoc trained medical doctors, interview-based information or measurement of some of the covariates was possibly imprecise. However Along this line was also the decision to investigate family history of MI only, and to leave aside other manifestations of CHD. The inclusion of the latter would have increased the numbers of exposed case and control patients but not the validity of the information collected, and hence, the strength of the association. It could also be argued that MI and "other" CHD do not necessarily fit the same etiopathogenetic model.
We did not collect data on risk factors in relatives such as diabetes and hypertension, information in which anamnestic assessment is unreliable. Absence of these covariates, however, should not explain any of the observed RRs, because allowance for these risk factors in the patients did not modify any of the risk estimates. Thus, it is unlikely that clustering of diabetes, hypertension, or other relevant risk factors for MI in families could by itself explain the family-related risks.
Our findings have potential clinical implications. Family history, which is easy and inexpensive to investigate, could be used to help identify people potentially at risk of developing CHD. Knowledge of their family history as well as an awareness of other recognized risk factors (in particular smoking, hypertension, and hypercholesterolemia, all of which can, in principle, be controlled) may help convince individuals to modify their lifestyles and thus reduce the risk of developing CHD. 
